Altered activity of cytochrome P450 in alcoholic fatty liver exposed to ischemia/reperfusion

被引:10
作者
Cho, Kang-Hun [1 ]
Lee, Sun-Mee [1 ]
机构
[1] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, Gyeonggi, South Korea
关键词
alcohol; cytochrome P450 isozymes; fatty liver; ischemia/reperfusion;
D O I
10.1007/BF02977778
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ischemia/reperfusion (I/R) injury is a major cause of morbidity and mortality in liver surgery and transplantation, and fatty livers are susceptible to greater I/R injury and a higher incidence of primary graft nonfunction after transplantation, Because alcohol intake and obesity are major causes of fatty liver, this study was initiated to investigate the effect of chronic ethanol consumption on hepatic microsomal cytochrome P450 (CYP) activity after I/R. Rats were fed an alcohol liquid diet or a control isocaloric diet for 4 weeks, and then subjected to 60 min of hepatic ischemia and 5 h of reperfusion. It was found that, chronic ethanol consumption significantly increased liver weight, serum triglyceride (TG), liver TG, and serum aminotransferase activities. Moreover, alcoholic fatty livers exposed to I/R showed significantly higher levels of aminotransferase activities than the controls. No significant differences in microsomal CYP content or CYP1A1 activity were found between I/R treated animals fed a control diet (the CID + I/R group) and I/R treated animals fed an ethanol containing diet (the ED + I/R group). Moreover, whereas CYP1A2 activity was decreased in the ED + I/R group versus the CD + I/R group, CYP2E1 activity was elevated. Additionally, chronic alcohol consumption up-regulated TNF-alpha and IL-6 mRNA levels immediately after I/R. In conclusion, chronic ethanol consumption was found to potentiate hepatocellular damage as indicated by abnormalities in microsomal drug metabolizing function during I/R.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 31 条
  • [1] Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    Belghiti, J
    Hiramatsu, K
    Benoist, S
    Massault, PP
    Sauvanet, A
    Farges, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 38 - 46
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Buege J A, 1978, Methods Enzymol, V52, P302
  • [4] ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450
    BURKE, MD
    THOMPSON, S
    ELCOMBE, CR
    HALPERT, J
    HAAPARANTA, T
    MAYER, RT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) : 3337 - 3345
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/reperfusion
    Eum, HA
    Lee, SM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (01) : 35 - 42
  • [7] Clinical features and natural history of nonalcoholic steatosis syndromes
    Falck-Ytter, Y
    Younossi, ZM
    Marchesini, G
    McCullough, AJ
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 17 - 26
  • [8] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [9] PURIFICATION AND CHARACTERIZATION OF MICROSOMAL CYTOCHROME-P-450S
    GUENGERICH, FP
    DANNAN, GA
    WRIGHT, ST
    MARTIN, MV
    KAMINSKY, LS
    [J]. XENOBIOTICA, 1982, 12 (11) : 701 - 716
  • [10] Models of alcoholic liver disease in rodents:: A critical evaluation
    Hall, PDM
    Lieber, CS
    DeCarli, LM
    French, SW
    Lindros, KO
    Järveläinen, H
    Bode, C
    Parlesak, A
    Bode, JC
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (05) : 254S - 261S